search
Back to results

Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study

Primary Purpose

Breast Cancer, Inflammatory Breast Cancer Stage IV, Inflammatory Breast Neoplasms

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Self-Administered Hypnosis
Self-Administered White Noise Hypnosis
Sponsored by
The University of Tennessee, Knoxville
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Breast Cancer focused on measuring breast cancer, cancer pain, pain management, hypnosis, Black or African American

Eligibility Criteria

18 Years - 99 Years (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria: 18 years of age or older Black female Diagnosed with Stage IV Breast Cancer with life expectancy of 6 months or more Ability to read and write English Ability to complete questionnaire(s) by themselves or with assistance. Report cancer-related pain that they rate as ≥4 on a numeric pain rating scale of 0-10 with 0 being "no pain" and 10 being "the worst it can be" for the past month or more. Ability to provide informed written consent. Exclusion Criteria: Diagnosis of major depressive disorder or acute anxiety disorder per the medical record or self-report in the past 2 years Serious psychological illness, specifically psychoses, schizophrenia, or borderline personality disorder per the medical record or self-report Currently enrolled in hospice Currently using hypnosis for any reason Non-English speaking Unable to complete questionnaires or follow directions independently.

Sites / Locations

  • University of Tennessee KnoxvilleRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Self-Administered Hypnosis

Self Administered White Noise Hypnosis

Arm Description

Self-administered hypnosis will be practiced daily, at home for 6 weeks. Hypnosis sessions are expected to last ~20 minutes. Practices using the recordings will be documented on the Hypnosis Practice Log.

Self-administered white noise hypnosis will be practiced daily using a white noise recording. Participants will practice hypnosis at home after completing the virtual consent/baseline visit and the virtual education visit.

Outcomes

Primary Outcome Measures

Screen failure rate (a measure of feasibility)
The number of women screened ineligible
Accrual rate (a measure of feasibility)
The number of participants who consented divided by the number eligible
Retention rate / acceptability (a measure of feasibility)
The number of participants who complete the 6 weeks of the study divided by the number who consented.

Secondary Outcome Measures

Participant experience
Determine factors affecting participant experience through open-ended interview questions.
Pain severity and Interference
Change in Brief Pain Inventory-Short Form scores. The Brief Pain Inventory-Short Form contains two subscales, pain severity and pain interference. Both scales include individual items that are scored on a scale of 0-10. The pain severity scale includes 4 items, with a possible range of 0-40. The pain interference scale includes 7 items, with a possible range 0-70. Higher scores indicate greater pain severity and greater pain interference.

Full Information

First Posted
September 19, 2023
Last Updated
September 26, 2023
Sponsor
The University of Tennessee, Knoxville
Collaborators
Baylor University
search

1. Study Identification

Unique Protocol Identification Number
NCT06057636
Brief Title
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
Official Title
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
September 8, 2023 (Actual)
Primary Completion Date
July 31, 2024 (Anticipated)
Study Completion Date
July 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The University of Tennessee, Knoxville
Collaborators
Baylor University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to compare two hypnotic interventions for Black women with advanced cancer pain in preparation for a well-powered phase III study. The investigators plan to enroll 30 adult Black women with advanced cancer pain in a 2-arm pilot randomized controlled trial (RCT). The primary aim will be to evaluate the feasibility of conducting the 2-arm clinical trial. It is hypothesized that at least 75% of participants in both study arms will complete study requirements. The secondary aims will be to evaluate the participant's experience with the intervention and to determine the effect size of the intervention on pain severity.
Detailed Description
Envision is a randomized, 2-arm, mixed-methods pilot study to evaluate the feasibility of translating a promising in-person hypnosis intervention for advanced cancer pain into a culturally appropriate, remotely delivered hypnosis intervention for pain in Black women with advanced cancer. The study is 6 weeks long and does not require any in-person visits. If a breast cancer survivor is determined eligible, they will be educated on the purpose, requirements, and procedures. If interested, participants will be emailed the consent form and will schedule a virtual consent/baseline visit. After consent is obtained, the participant will be randomly assigned to one of two types of hypnotic relaxation to be used alongside current pain treatment using 1:1 randomization and given a study number. The participant will complete online surveys at the virtual baseline visit. An MP3 player with hypnotic relaxation audio files will be sent to the participant's address and a virtual education visit will be scheduled. At this second virtual visit, participants will receive education about their study arm and a start date will be agreed upon for week 1. Beginning week 1 and continuing through week 6, participants will listen to their assigned hypnotic relaxation audio files daily and be asked to complete a weekly practice log. Participants will also continue to meet with study staff virtually for weekly check-ins. At these weekly meetings, progress and adverse events will be assessed and relevant online surveys will be completed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer, Inflammatory Breast Cancer Stage IV, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms, Neoplasm Metastasis
Keywords
breast cancer, cancer pain, pain management, hypnosis, Black or African American

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This is a two-arm, randomized clinical trial.
Masking
Participant
Masking Description
single-masking, participants
Allocation
Randomized
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Self-Administered Hypnosis
Arm Type
Experimental
Arm Description
Self-administered hypnosis will be practiced daily, at home for 6 weeks. Hypnosis sessions are expected to last ~20 minutes. Practices using the recordings will be documented on the Hypnosis Practice Log.
Arm Title
Self Administered White Noise Hypnosis
Arm Type
Active Comparator
Arm Description
Self-administered white noise hypnosis will be practiced daily using a white noise recording. Participants will practice hypnosis at home after completing the virtual consent/baseline visit and the virtual education visit.
Intervention Type
Behavioral
Intervention Name(s)
Self-Administered Hypnosis
Intervention Description
Participants will choose from one of three 20-minute prerecorded hypnosis audio files. Practices using the recordings will be documented on the hypnosis practice log.
Intervention Type
Behavioral
Intervention Name(s)
Self-Administered White Noise Hypnosis
Intervention Description
Participants will be listening to the same 20-minute white noise audio recording for 6 weeks and will be encouraged to practice daily. Practices using the recordings will be documented on the hypnosis practice log.
Primary Outcome Measure Information:
Title
Screen failure rate (a measure of feasibility)
Description
The number of women screened ineligible
Time Frame
Recruitment to screening (up to 3 months)
Title
Accrual rate (a measure of feasibility)
Description
The number of participants who consented divided by the number eligible
Time Frame
Screening to consent (up to 30 days)
Title
Retention rate / acceptability (a measure of feasibility)
Description
The number of participants who complete the 6 weeks of the study divided by the number who consented.
Time Frame
Baseline through study completion, 6 weeks
Secondary Outcome Measure Information:
Title
Participant experience
Description
Determine factors affecting participant experience through open-ended interview questions.
Time Frame
consent to week 6
Title
Pain severity and Interference
Description
Change in Brief Pain Inventory-Short Form scores. The Brief Pain Inventory-Short Form contains two subscales, pain severity and pain interference. Both scales include individual items that are scored on a scale of 0-10. The pain severity scale includes 4 items, with a possible range of 0-40. The pain interference scale includes 7 items, with a possible range 0-70. Higher scores indicate greater pain severity and greater pain interference.
Time Frame
consent to week 6

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 18 years of age or older Black female Diagnosed with Stage IV Breast Cancer with life expectancy of 6 months or more Ability to read and write English Ability to complete questionnaire(s) by themselves or with assistance. Report cancer-related pain that they rate as ≥4 on a numeric pain rating scale of 0-10 with 0 being "no pain" and 10 being "the worst it can be" for the past month or more. Ability to provide informed written consent. Exclusion Criteria: Diagnosis of major depressive disorder or acute anxiety disorder per the medical record or self-report in the past 2 years Serious psychological illness, specifically psychoses, schizophrenia, or borderline personality disorder per the medical record or self-report Currently enrolled in hospice Currently using hypnosis for any reason Non-English speaking Unable to complete questionnaires or follow directions independently.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Noel M Arring, DNP, PhD, RN
Phone
(865) 974-1988
Email
CASSI@utk.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Carrie K Lafferty, PhD
Phone
865-974-0500
Email
claffer2@utk.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Noel M Arring, DNP, PhD, RN
Organizational Affiliation
University of Tennessee Knoxville
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Tennessee Knoxville
City
Knoxville
State/Province
Tennessee
ZIP/Postal Code
37996
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Noel M Arring, DNP,PhD,RN
Phone
865-974-1988
Email
cassi@utk.edu
First Name & Middle Initial & Last Name & Degree
Carrie K Lafferty, PhD
Phone
865-974-0500
Email
claffer2@utk.edu
First Name & Middle Initial & Last Name & Degree
Noel M Arring, DNP, PdD, RN

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
This is a small pilot study and as such, data will be thoroughly interrogated. However, if an investigator feels there are unanswered questions or wishes to add to a larger dataset, we would entertain all data-sharing requests for deidentified data as appropriate.

Learn more about this trial

Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study

We'll reach out to this number within 24 hrs